Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Study hypothesis:
A 6-week p.o treatment with 5 mg/Kg Coenzyme Q10 is safe and tolerable,increases the brain's
metabolism and ameliorates clinical symptoms in patients with PSP.
Phase:
Phase 2
Details
Lead Sponsor:
German Parkinson Study Group (GPS)
Collaborators:
MSE Pharmazeutika GmbH, Louisenstr.114D-61348 Bad Homburg, Germany Philipps University Marburg Medical Center Pitzer Stiftung